Alembic Pharmaceuticals Limited (APLLTD.BO)

INR 1045.0

(-1.04%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 64.45 Billion 61.82 Billion 71.22 Billion 67.08 Billion 59.89 Billion 47.77 Billion
Total Current Assets 30.78 Billion 29.1 Billion 28.6 Billion 26.52 Billion 24.62 Billion 19.57 Billion
Cash And Short Term Investments 1.26 Billion 754.8 Million 610.9 Million 2.85 Billion 718.4 Million 1.99 Billion
Cash and Cash Equivalents 1.26 Billion 754.8 Million 610.9 Million 980.6 Million 718.4 Million 1.99 Billion
Short Term Investments 271.3 Million 166.4 Million 316.2 Million 1.86 Billion - -
Net Receivables 10.24 Billion 10.51 Billion 8.11 Billion 3.53 Billion 8.72 Billion 4.94 Billion
Inventory 16.43 Billion 14.75 Billion 16.09 Billion 14.86 Billion 11.87 Billion 9.67 Billion
Other Current Assets 2.83 Billion 2.13 Billion 200 Thousand -100 Thousand 200 Thousand 1.76 Billion
Total Non-Current Assets 33.67 Billion 32.72 Billion 42.61 Billion 40.56 Billion 35.26 Billion 28.2 Billion
Net PPE 30.71 Billion 29.99 Billion 39.47 Billion 36.47 Billion 30.99 Billion 24.39 Billion
Good Will And Intangible Assets -100 Thousand - 1.54 Billion 3.23 Billion 2.99 Billion 2.69 Billion
Good Will - - - - - 36 Million
Intangible Assets - - 1.54 Billion 3.23 Billion 2.99 Billion 2.66 Billion
Long-Term Investments 930.2 Million 963.3 Million 1.18 Billion 493.1 Million 176.2 Million 487.6 Million
Tax Assets 1.69 Billion 1.23 Billion 58.8 Million 1.84 Billion 1.48 Billion 1.22 Billion
Other Non Current Assets 333 Million 537.4 Million 348.7 Million -1.48 Billion -374.1 Million -607 Million
Other Assets - - - 100 Thousand - 0.00
Total Liabilities 16.27 Billion 18.12 Billion 18.84 Billion 16.42 Billion 27.98 Billion 20.59 Billion
Total Current Liabilities 14.54 Billion 16.36 Billion 17.16 Billion 12.8 Billion 17.51 Billion 14.89 Billion
Account Payables 7.35 Billion 6.79 Billion 7.06 Billion 6.68 Billion 6.25 Billion 6.44 Billion
Tax Payables - - - 21.5 Million - 36.1 Million
Short Term Debt 4.5 Billion 6.52 Billion 6.44 Billion 3.12 Billion 8.7 Billion 6.29 Billion
Deferred Revenue 157.6 Million 396.2 Million 692.2 Million 235.2 Million 64.9 Million 36.2 Million
Other Current Liabilities 2.53 Billion 2.64 Billion 2.95 Billion 2.76 Billion 2.48 Billion 2.12 Billion
Total Non Current Liabilities 1.72 Billion 1.75 Billion 1.67 Billion 3.61 Billion 10.47 Billion 5.7 Billion
Long-Term Debt 628.8 Million 692.3 Million 721.4 Million 2.71 Billion 9.6 Billion 4.99 Billion
Deferred Revenue Non Current -1.31 Billion 230.6 Million -1.01 Billion 855.2 Million 745.1 Million 520.3 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.09 Billion 200 Thousand -100 Thousand 200 Thousand 100 Thousand 300 Thousand
Other Liabilities 1.00 - - - - -0.00
Total Equity 48.18 Billion 43.7 Billion 52.37 Billion 50.06 Billion 31.9 Billion 27.18 Billion
Stock Holders Equity 48.18 Billion 43.7 Billion 52.37 Billion 50.66 Billion 32.19 Billion 27.18 Billion
Common Stock 393.1 Million 393.1 Million 393.1 Million 393.1 Million 377 Million 377 Million
Retained Earnings 40.27 Billion 35.68 Billion 25.54 Billion 23.84 Billion 15.38 Billion 12.86 Billion
Accumulated other comprehensive income 3.9 Million 7.87 Billion 7.87 Billion 7.87 Billion 377 Million 377 Million
Common Stock Equity 48.18 Billion 43.7 Billion 52.37 Billion 50.66 Billion 32.19 Billion 27.18 Billion
Capital Lease Obligation 628.8 Million 861.5 Million 871.2 Million 838.2 Million 832 Million -
Total Investments 930.2 Million 963.3 Million 1.18 Billion 493.1 Million 176.2 Million 487.6 Million
Total Debt 5.13 Billion 7.22 Billion 7.17 Billion 5.83 Billion 18.3 Billion 11.28 Billion
Net Debt 3.86 Billion 6.46 Billion 6.56 Billion 4.85 Billion 17.58 Billion 9.29 Billion

Balance Sheet Charts